Comment from Vie Sante Medical

Summary: Vie Santé Medical, a healthcare provider, supports the inclusion of racemic ketamine in the FDA's drug repurposing initiative for unmet medical needs. They argue that ketamine has a strong evidence base for treating treatment-resistant depression and chronic pain, but lacks commercial incentive for manufacturers to seek formal approval.